The Monday Press

April 2024

HIV News Around The Globe

Zimbabwe has introduced Cabotegravir long-acting (CAB-LA), an injectable pre-exposure prophylaxis drug, to add to the HIV prevention regime in the country.

The drug, an ARV designed to suppress any infection as it occurs, is for HIV-negative people who have a high risk of becoming infected with HIV.

It is the third pre-exposure prophylaxis (PrEP) product to be introduced in demonstration sites under a study for catalysing access to new prevention products to stop HIV (CATALYST).

The study has introduced the dapivirine ring and oral PrEP as HIV prevention choices for women and CAB-LA becomes the third product to be made available.

You can read more about this report here 

IAS- the International AIDS Society is deeply concerned about the HIV response in Uganda following its Constitutional Court’s ruling to uphold the Anti-Homosexuality Act today.  

As the world’s largest association of people living with, affected by and working on HIV, the IAS calls on Uganda to put people first and reverse this devastating law, which threatens its own citizens and prevents an effective HIV response. 

“The court had the opportunity to set matters right, but it has failed to follow the science and heed evidence,” IAS President Sharon Lewin said. “The ruling is completely at odds with Uganda’s stated commitment to ending HIV as a threat to public health by 2030. The consequences for the HIV response, not just in Uganda, but in other African countries grappling with anti-gay sentiment, are severe.

You can read more about the statement here 

Under the Tree- April Edition

We're excited to announce the upcoming session of Under the Tree, WACI Health's youth leadership and advocacy programme aimed at bolstering youth leadership in Global Health.

Our monthly forum is scheduled for April 25th, 2024 (3PM SAST/ 4PM EAT/ 4PM WAT) and the theme is " "Tomorrow's Advocates: The Vital Role of Young People in HIV Prevention".

Let’s prepare to attend.Please Register here

After registering, you will receive a confirmation email containing information about joining the meeting.

Copyright © 2024, All rights reserved.

Our mailing address is:
info@afnhi.org

Want to change how you receive these emails?
You can unsubscribe from this list.